Dr. Arber is an internationally recognized expert in the diagnosis and classification of hematopoietic tumors, including malignant lymphoma, acute and chronic leukemia, myeloproliferative disorders, myelodysplastic syndrome and tumors of the spleen.
City of Hope National Medical Center
Duarte, California
- Hematopathology
1993
E.A. Conway Memorial Hospital
Monroe, Lousiana
- Internship
1987
University of Texas Health Science Center at San Antonio
San Antonio, Texas
MD - Medicine
1986
Texas A&M University
College Station, Texas
BS - Zoology
1983
Scott and White Memorial Hospital
Temple, Texas
- Anatomic and Clinical Pathology
06,1991
Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with =5% blasts: An International TP53 Investigators Network (iTiN) study.
Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with =5% blasts: An International TP53 Investigators Network (iTiN) study. Cancer. 2026 Jan 01; 132(1):e70210.
PMID: 41417597
Karyotypic clonal fraction predicts adverse outcome in TP53-mutated myeloid neoplasms: an International TP53 investigators Network (iTiN) study.
Karyotypic clonal fraction predicts adverse outcome in TP53-mutated myeloid neoplasms: an International TP53 investigators Network (iTiN) study. J Clin Pathol. 2025 Aug 18; 78(9):629-635.
PMID: 40571403
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults.
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults. Blood Cancer J. 2025 Aug 14; 15(1):138.
PMID: 40813576
A Clinically Applicable Model Using Blood Counts to Support the Diagnosis of Prefibrotic Myelofibrosis Versus Essential Thrombocythemia.
A Clinically Applicable Model Using Blood Counts to Support the Diagnosis of Prefibrotic Myelofibrosis Versus Essential Thrombocythemia. Am J Hematol. 2025 Oct; 100(10):1772-1778.
PMID: 40716107
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations.
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations. Blood Adv. 2025 Jul 08; 9(13):3370-3380.
PMID: 40085954
Systemic Mastocytosis in 910 Patients: Prognostic Contribution of the International Consensus Classification in the Context of the Mayo Alliance Prognostic System.
Systemic Mastocytosis in 910 Patients: Prognostic Contribution of the International Consensus Classification in the Context of the Mayo Alliance Prognostic System. Am J Hematol. 2025 Sep; 100(9):1566-1576.
PMID: 40607735
The Classification of Hematopoietic Neoplasms: The Why, How, and Who?
The Classification of Hematopoietic Neoplasms: The Why, How, and Who? Adv Anat Pathol. 2025 Jul 01; 32(4):257-258.
PMID: 40476346
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT.
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT. Blood. 2025 May 29; 145(22):2561-2573.
PMID: 40106773
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort.
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort. Blood Cancer J. 2025 May 07; 15(1):88.
PMID: 40335478
Prognostic Validation of the International Consensus (ICC) Re-Classification of Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC) Into Genetic Subcategories.
Prognostic Validation of the International Consensus (ICC) Re-Classification of Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC) Into Genetic Subcategories. Am J Hematol. 2025 Jun; 100(6):948-950.
PMID: 40172083
Chicago Magazine Top Doctor
2018 - 2019
Endowed Chair: Donald West and Mary Elizabeth King Professor and Chair of Pathology
University of Chicago
2018
President, Society for Hematopathology
2016 - 2018
Endowed Chair: Ronald F. Dorfman, MBBch, FRCPath Professor in Hematopathology
Stanford University
2013 - 2016
Clinical Pathology Senior Faculty Teaching Award
Stanford University
2010
School of Medicine Teaching Excellence Award
Stanford University
2009 - 2011
Distinguished Alumnus Award
Scott & White Clinic
2008
America's Top Doctors
2006 - 2019
Best Doctors in America
2005 - 2019